BEIJING, May 13, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc.("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, today announced that InfiniClone Limited ("InfiniClone"), Shineco's majority-owned subsidiary in which the Company acquired a 51% equity interest on April 25, 2025, has officially launched its Southeast Asian market expansion strategy as it has reached a strategic distribution agreement with Total World Marketing (Thailand) ("TWM"), pursuant to which TWM will be responsible for the promotion and sale of InfiniClone’s molecular detection kits and InfiniClone’s Purelix series health products in the Southeast Asian market.
Actual results may differ materially from those indicated in historical results or forward-looking statements due to various factors, including, but not limited to, the Company's ability to raise additional capital, its ability to maintain and grow its business, the variability of its results of operations, its ability to maintain and enhance its brand, its ability to develop and introduce new products and services, its ability to obtain all necessary regulatory approvals in the jurisdictions in which it intends to market and sell its products, Companies to be acquired, Successful integration of technology and assets into its portfolio of products and services Marketing and other business development initiatives Industry competition, general government regulations, economic conditions, impact of the COVID-19 pandemic, reliance on key personnel, attracting, hiring and retaining personnel with the technical skills and experience required to meet customer requirements and protect intellectual property.
Lim Kah Meng, founder of InfiniClone, commented, "The breakthrough application of our iPSC technology serves as the basis for the accuracy of InfiniClone’s two products, and we anticipate TWM's extensive coverage in supermarket channels will provide a solid foundation for our initial market penetration.
The story "Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market" has 1157 words across 30 sentences, which will take approximately 5 - 10 minutes for the average person to read.
Which news outlet covered this story?
The story "Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market" was covered 3 days ago by GlobeNewswire, a news publisher based in United States.
How trustworthy is 'GlobeNewswire' news outlet?
GlobeNewswire is a fully independent (privately-owned) news outlet established in 1998 that covers mostly startups news.
The outlet is headquartered in United States and publishes an average of 0 news stories per day.
It's most recent story was published 3 days ago.
What do people currently think of this news story?
The sentiment for this story is currently Negative, indicating that people regard this as "bad news".
How do I report this news for inaccuracy?
You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
